Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-10-23 Net Asset Value
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Delårsrapport for de første ni måneder af 2019
Net Asset Value Classification · 98% confidence The document text is extremely short (481 characters) and contains Danish text instructing the reader to 'Læs venligst hele meddelesen i den vedhæftede PDF' (Please read the entire announcement in the attached PDF). It explicitly points to an 'Vedhæftet fil' (Attached file) which is a link to a document named '2019_44_Q32019_CompanyAnnouncement_DK_FINAL'. According to the 'MENU VS MEAL' rule, a short document whose primary purpose is to announce the publication of another report (especially one referencing an attachment/link) should be classified as a Report Publication Announcement (RPA).
2019-10-23 English
Transactions under Novozymes’ stock buyback program
Report Publication Announcement Classification · 100% confidence The document is extremely short (469 characters) and serves as a landing page or notification for an attached PDF file titled '2019_43_Stock_Buybackprogram_EN'. It explicitly instructs the reader to 'read the full announcement in the attached PDF'. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the underlying report itself.
2019-10-21 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Report Publication Announcement Classification · 95% confidence The document text is extremely short (465 characters) and explicitly states: 'Læs venligst hele meddelelsen i vedhæftede fil' (Please read the entire announcement in the attached file) and provides a link to an attachment named '2019_43_Stock_Buybackprogram_DK'. This structure—a brief announcement pointing to a detailed attachment—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), based on the 'MENU VS MEAL' rule. Given the attachment title mentions 'Stock_Buybackprogram', the content relates to the company transacting in its own shares. However, since the provided text is only the announcement wrapper and not the actual buyback details, RPA is the most appropriate classification for the wrapper document itself, as it announces the publication of the main information. If the attachment were analyzed, POS would be likely, but for this wrapper, RPA is chosen.
2019-10-21 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of transactions related to Novozymes' share buyback program, including the number of shares repurchased, transaction values, dates, and prices. It references compliance with market abuse regulations and provides detailed trading data. There is no indication of financial statements, earnings data, or management discussion. The content focuses exclusively on the company's repurchase of its own shares. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on share repurchase activities. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement of a report. Therefore, the correct classification is POS with high confidence.
2019-10-21 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a short announcement regarding 'Novozymes’ aktietilbagekøbsprogram' (Novozymes' share buyback program). It explicitly directs the reader to an attached file for the details of the transactions. Following the 'Menu vs Meal' rule, since this is a short announcement of a report/data file rather than the full report itself, it is classified as a Report Publication Announcement.
2019-10-21 Danish
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled 'Transactions under Novozymes’ stock buyback program'. This structure indicates an announcement about a transaction rather than the detailed report itself. The content specifically concerns the company's stock buyback program, which falls under the category of 'Transaction in Own Shares' (POS). Given the short nature and the instruction to read the full announcement elsewhere, it is a Report Publication Announcement (RPA) or the specific transaction type (POS). Since POS is a specific category for share repurchase/issuance, and the content directly relates to a buyback program, POS is the most accurate classification, even though it is presented as a brief announcement.
2019-10-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.